Advertisement

Journal of Endocrinological Investigation

, Volume 2, Issue 3, pp 257–260 | Cite as

Effects of somatostatin on insulin and glucagon in patients with insulinoma

  • Franco Fallucca
  • C. Mirabella
  • G. Tamburrano
  • S. Gambardella
  • G. Aufieri
  • F. Barbetti
  • D. Andreani
Article

Abstract

Effects of somatostatin on fasting and arginine- or tolbutamide-stimulated insulin release were studied in four patients with insulinoma. Somatostatin (bolus or bolus + infusion) reduced fasting insulin values in all patients; insulin response to tolbutamide was partially reduced in two patients; somatostatin bolus impaired the insulin response to arginine. Fasting glucagon levels and glucagon response to arginine were also reduced by somatostatin. These results indicate the potential usefulness of somatostatin in the diagnosis of insulinoma even if its effect on insulin is only partial.

Key-words

Glucagon insulin insulinoma somatostatin tolbutamide arginine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Siler T.M., Vanderberg G., Yen S.S.C., Brazeau P., Vale W., Guillemin R. Inhibition of growth hormone release in human by somatostatin. J. Clin. Endocrinol. Metab. 37: 632, 1973.PubMedCrossRefGoogle Scholar
  2. 2.
    Hall R., Schally A.V., Evered D., Kastin A.J., Mortimer C.M., Tunbridge W.M.G., Besser G.M., Coy D.M., Goldie D.J., McNeilly A.S., Phenekos C., Weightan D. Action of growth hormone release inhibitory hormone in healthy men and in acromegaly. Lancet 1: 581, 1973.CrossRefGoogle Scholar
  3. 3.
    Copinschi G., Virasoro E., Vanhaelst L., Leclercq R., Golstein J., L’Hermite M. Specific inhibition by somatostatin of growth hormone release after hypoglycemia in normal men. Clin. Endocrinol. (Oxf.) 3: 441, 1974.CrossRefGoogle Scholar
  4. 4.
    Alberti K.G.M., Christensen N.J., Christensen S.E., Prange Hansen A.A., Iversen J., Lundbaek H.K., Seyer-Hansen J., Orskow H. Inhibiton of insulin secretion by somatostatin. Lancet 2: 1299, 1973.PubMedCrossRefGoogle Scholar
  5. 5.
    Curry D.L., Bennet L.L., Li C.M. Direct inhibition of insulin secretion by synthetic somatostatin. Biochem. Biophys. Res. Commun. 58: 885, 1974.PubMedCrossRefGoogle Scholar
  6. 6.
    Fujmoto W.Y., Ensick J.W., Williams R.M. Somatostatin inhibits insulin and glucagon release by monolayer cells culture of rat endocrine pancreas. Life Sci. 16: 1999, 1974.CrossRefGoogle Scholar
  7. 7.
    Koerker D., Ruch W., Chideckel G., Palmer J., Goodner C., Ensick J.E., Gale C. Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science 184: 482, 1974.PubMedCrossRefGoogle Scholar
  8. 8.
    Yen S.S.C, Siler T.M., De Vane G.W. Effect of somatostatin in patients with acromegaly. N. Engl. J. Med. 290: 935, 1974.PubMedCrossRefGoogle Scholar
  9. 9.
    Besser G.M., Mortimer C.M., Larr D., Schally A.V., Coy D.H., Evered D., Kastin A.J., Tunbridge W.M.G., Thorner M.O., Hall R. Growth hormone release inhibiting hormone in acromegaly. Br. J. Med. 1: 352, 1974.CrossRefGoogle Scholar
  10. 10.
    Christensen S.E., Hansen A.P., Lunbaek K., Orskow M., Sayer-Hansen K. Somatostatin and insulinoma. Lancet 1: 1426, 1975.PubMedCrossRefGoogle Scholar
  11. 11.
    Curnow R.T., Carey R.M., Taylor A., Johanson A., Murad F. Somatostatin inhibition of insulin and gastrin hypersecretion in pancreatic islet cell carcinoma. N. Engl. J. Med. 292: 1385, 1975.PubMedCrossRefGoogle Scholar
  12. 12.
    Lorenzi M., Gerich J.E., Karam J.M., Forsham S.M. Failure of somatostatin to inhibit tolbutamide-induced insulin secretion in patients with insulinoma: a possible diagnostic tool. J. Clin. Endocrinol. Metab. 40: 1121, 1975.PubMedCrossRefGoogle Scholar
  13. 13.
    Berchtold P., Berger M., Wiegenman W., Cuppers M.J., Grunneklee D., Reminwein D., Gries F.A., Zimmermann M. Serum insulin suppression by somatostatin, diazoxide and Phenytoin in insulinoma patients. V International Congress of Endocrinology, Hamburg July 18-24, 1976, Abstract 229.Google Scholar
  14. 14.
    Scuro L.A., Lo Cascio V., Adami S., Galvanini G., Bianchi I., Cominacini L., Corgnati A. Somatostatin inhibition of insulin secretion in insulin producing tumors. Metabolism 6: 603, 1976.CrossRefGoogle Scholar
  15. 15.
  16. 16.
    Hoffman W.S. A rapid photoelectric method for the determination of glucose in blood and urine. J. Biochem. (Tokyo), 120: 51, 1937.Google Scholar
  17. 17.
    Hales C.N., Randle P.J. Immunoassay of insulin with insulin antibody precipitate. Biochem. J. 88: 137, 1963.PubMedCentralPubMedGoogle Scholar
  18. 18.
    Aguilar-Parada E., Eisentraut A.M. Unger R.H. Pancreatic secretion in normal and diabetic subjects. Am. J. Med. Sci. 257: 415, 1969.PubMedCrossRefGoogle Scholar
  19. 19.
    Fallucca F., Tamburrano S., Gambardella S., Menzinger G. Response of islet cells tumors to enterohormones. Horm. Metab. Res. (Suppl. 6) 34, 1976.PubMedGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1979

Authors and Affiliations

  • Franco Fallucca
    • 1
  • C. Mirabella
    • 1
  • G. Tamburrano
    • 1
  • S. Gambardella
    • 1
  • G. Aufieri
    • 1
  • F. Barbetti
    • 1
  • D. Andreani
    • 1
  1. 1.II Clinica Medica, Cattedra di Endocrinologia e Malattie Metaboliche, Policlinico Umberto IUniversity of RomaRomaItaly

Personalised recommendations